Blue Check Labs LLC – Trademark Portfolio
Entity Type: 16
Blue Check Labs LLC has 5 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 2 are successfully registered — a 67% registration rate, with 2 applications currently pending. The portfolio includes marks such as TAKE PRIDE and SCOTT'S TOTS. Filings span 4 Nice Classification classes, with the highest activity in Class 24 (Fabrics) and Class 5 (Pharmaceuticals). This trademark owner is based in Las Vegas, NV.
6415 S Fort Apache Rd Ste 185-1138
Las Vegas, NV 89148
Showing of trademarks Trademarks
Trademark Classifications
Blue Check Labs LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does Blue Check Labs LLC have?
Blue Check Labs LLC has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 pending, 1 abandoned.
What trademark classes does Blue Check Labs LLC file in?
Blue Check Labs LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 24 (Fabrics), Class 5 (Pharmaceuticals), Class 30 (Staple Foods), Class 28 (Toys & Sporting Goods). Class 24 covers textiles and textile goods; bed covers; table covers.
What are Blue Check Labs LLC's most well-known trademarks?
Blue Check Labs LLC's registered trademark portfolio includes well-known marks such as TAKE PRIDE and SCOTT'S TOTS. These are among 2 currently registered trademarks in the portfolio.
What is Blue Check Labs LLC's trademark registration success rate?
Blue Check Labs LLC has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 2 applications are pending review.